Haruo Iwabuchi

713 total citations
34 papers, 578 citations indexed

About

Haruo Iwabuchi is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Haruo Iwabuchi has authored 34 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 14 papers in Pharmacology and 8 papers in Oncology. Recurrent topics in Haruo Iwabuchi's work include Pharmacogenetics and Drug Metabolism (12 papers), Drug Transport and Resistance Mechanisms (8 papers) and Peroxisome Proliferator-Activated Receptors (7 papers). Haruo Iwabuchi is often cited by papers focused on Pharmacogenetics and Drug Metabolism (12 papers), Drug Transport and Resistance Mechanisms (8 papers) and Peroxisome Proliferator-Activated Receptors (7 papers). Haruo Iwabuchi collaborates with scholars based in Japan, Germany and United States. Haruo Iwabuchi's co-authors include Toshihiko Ikeda, K Nakamura, Takahiro Murai, Minoru Uchiyama, TORU KOMAI, Tomoko Ikeda, Hidekuni Takahagi, Akihiko Nakagawa, Tsuyoshi Yokoi and Hiroshi Yamazaki and has published in prestigious journals such as Biochemical and Biophysical Research Communications, International Journal of Cancer and Tetrahedron.

In The Last Decade

Haruo Iwabuchi

34 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haruo Iwabuchi Japan 14 260 222 167 64 54 34 578
Paul Toren United States 11 206 0.8× 284 1.3× 193 1.2× 74 1.2× 96 1.8× 22 661
Tsutomu Yoshimura Japan 13 205 0.8× 171 0.8× 183 1.1× 34 0.5× 73 1.4× 28 594
Susan Wong United States 17 220 0.8× 314 1.4× 248 1.5× 46 0.7× 57 1.1× 39 833
Xavier Boulenc France 15 198 0.8× 336 1.5× 303 1.8× 54 0.8× 78 1.4× 19 814
F. Peter Guengerich United States 12 261 1.0× 362 1.6× 189 1.1× 47 0.7× 42 0.8× 16 702
Jackie C. Bloomer United Kingdom 13 261 1.0× 268 1.2× 180 1.1× 58 0.9× 50 0.9× 20 751
Anima Ghosal United States 16 224 0.9× 446 2.0× 273 1.6× 80 1.3× 98 1.8× 28 946
Justin D. Lutz United States 16 252 1.0× 294 1.3× 219 1.3× 39 0.6× 79 1.5× 21 838
P. Marathe United States 12 162 0.6× 253 1.1× 360 2.2× 51 0.8× 100 1.9× 19 745
Nancy Eddy Hopkins United States 17 306 1.2× 434 2.0× 197 1.2× 61 1.0× 50 0.9× 25 905

Countries citing papers authored by Haruo Iwabuchi

Since Specialization
Citations

This map shows the geographic impact of Haruo Iwabuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haruo Iwabuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haruo Iwabuchi more than expected).

Fields of papers citing papers by Haruo Iwabuchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haruo Iwabuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haruo Iwabuchi. The network helps show where Haruo Iwabuchi may publish in the future.

Co-authorship network of co-authors of Haruo Iwabuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Haruo Iwabuchi. A scholar is included among the top collaborators of Haruo Iwabuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haruo Iwabuchi. Haruo Iwabuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Inaba, Shin‐ichi, Tomoko Ikeda, Maki Goto, et al.. (2015). Pharmacokinetics and disposition of CS-0777, a sphingosine 1-phosphate receptor modulator, in rats and monkeys. Xenobiotica. 45(12). 1063–1080. 3 indexed citations
2.
Iwabuchi, Haruo, et al.. (2012). Glutathione S-transferase pi trapping method for generation and characterization of drug–protein adducts in human liver microsomes using liquid chromatography–tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 67-68. 186–192. 12 indexed citations
3.
Uchiyama, Minoru, Thomas M. Fischer, Juergen Mueller, et al.. (2011). In Vitro Metabolism of Rivoglitazone, a Novel Peroxisome Proliferator-Activated Receptor γ Agonist, in Rat, Monkey, and Human Liver Microsomes and Freshly Isolated Hepatocytes. Drug Metabolism and Disposition. 39(7). 1311–1319. 4 indexed citations
4.
Uchiyama, Minoru, Thomas M. Fischer, Juergen Mueller, et al.. (2010). Identification of Novel Metabolic Pathways of Pioglitazone in Hepatocytes: N-Glucuronidation of Thiazolidinedione Ring and Sequential Ring-Opening Pathway. Drug Metabolism and Disposition. 38(6). 946–956. 15 indexed citations
5.
Uchiyama, Minoru, et al.. (2010). Pharmacokinetics, Metabolism, and Disposition of Rivoglitazone, a Novel Peroxisome Proliferator-Activated Receptor γ Agonist, in Rats and Monkeys. Drug Metabolism and Disposition. 39(4). 653–666. 8 indexed citations
6.
Hagihara, Katsunobu, Miho Kazui, Atsushi Kurihara, et al.. (2010). Biotransformation of Prasugrel, a Novel Thienopyridine Antiplatelet Agent, to the Pharmacologically Active Metabolite. Drug Metabolism and Disposition. 38(6). 898–904. 23 indexed citations
7.
Murai, Takahiro, Naotoshi Yamamura, Makoto Takei, et al.. (2007). Isolation and Identification of Diglucuronides of Some Endogenous Steroids in Dogs. Drug Metabolism and Disposition. 36(2). 368–374. 3 indexed citations
8.
Kotsuma, Masakatsu, Taro Tokui, Haruo Iwabuchi, et al.. (2007). CYP2D6-Mediated Metabolism of a Novel Acyl Coenzyme A:Cholesterol Acyltransferase Inhibitor, Pactimibe, and Its Unique Plasma Metabolite, R-125528. Drug Metabolism and Disposition. 36(3). 529–534. 4 indexed citations
9.
Fujimoto, Kazunori, Shingo Arakawa, Yukio Ando, et al.. (2006). Characterization of Phenotypes in Gstm1-null Mice by Cytosolic and in Vivo Metabolic Studies Using 1,2-Dichloro-4-Nitrobenzene. Drug Metabolism and Disposition. 34(9). 1495–1501. 22 indexed citations
10.
Murai, Takahiro, Haruo Iwabuchi, & Toshihiko Ikeda. (2005). Repeated Glucuronidation at One Hydroxyl Group Leads to Structurally Novel Diglucuronides of Steroid Sex Hormones. Drug Metabolism and Pharmacokinetics. 20(4). 282–293. 15 indexed citations
11.
Murai, Takahiro, et al.. (2002). Formation of a Structurally Novel, Serial Diglucuronide of 4-Hydroxybiphenyl by Further Glucuronidation of a Monoglucuronide in Dog Liver Microsomes. Drug Metabolism and Pharmacokinetics. 17(5). 457–466. 5 indexed citations
12.
Uchiyama, Minoru, Tomoko Kondo, Haruo Iwabuchi, et al.. (2001). Inhibition of In Vitro Metabolism of Simvastatin by Itraconazole in Humans and Prediction of In Vivo Drug-Drug Interactions. Pharmaceutical Research. 18(5). 622–631. 39 indexed citations
13.
Suzuki, Masako, Tomowo Kobayashi, Kazuo Tanaka, et al.. (1999). Antitumor activity and novel DNA-self-strand-breaking mechanism of CNDAC (1-(2-C-cyano-2-deoxy-?-d-ARABINO-Pentofuranosyl) cytosine) and itsN4-palmitoyl derivative (CS-682). International Journal of Cancer. 82(2). 226–236. 46 indexed citations
14.
Iwabuchi, Haruo, et al.. (1995). Studies on drug metabolism using LC/atmospheric pressure chemical ionization-MS.. BUNSEKI KAGAKU. 44(3). 181–188. 2 indexed citations
15.
Tamura, N., et al.. (1993). Biotransformation of Pravastatin Sodium(I). Biochemical and Biophysical Research Communications. 192(2). 597–602. 34 indexed citations
16.
Iwabuchi, Haruo, Yasushi Matsushita, Tsuyoshi Nakamura, et al.. (1992). Metabolism of pravastatin sodium in isolated rat hepatocytes. I. Glutathione conjugate formation reaction. Xenobiotica. 22(5). 487–498. 15 indexed citations
17.
Nakagawa, Akihiko, et al.. (1991). Simultaneous determination of gemfibrozil and its metabolites in plasma and urine by a fully automated high performance liquid chromatographic system. Biomedical Chromatography. 5(2). 68–73. 33 indexed citations
18.
Ikeda, T., Izumi C. Mori, Kuniaki Fukuda, et al.. (1988). Induction of Peroxisome Proliferation in Rat Liver by Dietary Treatment with 2,2,4,4,6,8,8-Heptamethylnonane. Xenobiotica. 18(11). 1271–1280. 11 indexed citations
19.
Iwabuchi, Haruo, et al.. (1988). Analysis of non-volatile compounds by off-line LC/MS.. BUNSEKI KAGAKU. 37(2). 88–93. 3 indexed citations
20.
Iwabuchi, Haruo, Akihiko Nakagawa, & K Nakamura. (1987). Application of molecular-secondary-ion mass spectrometry for drug metabolism studies. Journal of Chromatography B Biomedical Sciences and Applications. 414(1). 139–148. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Toren Breakdown of academic impact, for papers by Tsutomu Yoshimura Breakdown of academic impact, for papers by Susan Wong Breakdown of academic impact, for papers by Xavier Boulenc Breakdown of academic impact, for papers by F. Peter Guengerich Breakdown of academic impact, for papers by Jackie C. Bloomer Breakdown of academic impact, for papers by Anima Ghosal Breakdown of academic impact, for papers by Justin D. Lutz Breakdown of academic impact, for papers by P. Marathe Breakdown of academic impact, for papers by Nancy Eddy Hopkins
Rankless by CCL
2026